High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70566 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Kanteera Sriyudthsak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Re…. Hauptthemen laut MEDLINE: Omeprazole, Peptic Ulcer Hemorrhage, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Gastroenterological Association of Thailand (GAT), Guardian Angel Thrift.
Abstract (Originalsprache)
Background and Aim The efficacy of high‐dose oral omeprazole in peptic ulcer bleeding after successful therapeutic hemostatic endoscopy has not been well established. This study aimed to compare the efficacy of high‐dose oral omeprazole versus continuous intravenous (IV) pantoprazole in rebleeding and percent time of gastric pH above 6.
Methods
Eligible patients were randomized with 1:1 concealed allocation to 40‐mg oral omeprazole twice daily or IV pantoprazole 8 mg/h for 72 h after index gastroscopy. Gastric pH was measured for 24 h during 48–72 h after starting the assigned medication. Rebleeding at 72 h and 30 days, as well as 24‐h gastric pH, were assessed.
Results
A total of 124 patients were analyzed. Seventy‐two‐hour rebleeding occurred in 1.6% (1/61) of the oral omeprazole group and 4.8% (3/63) of the IV pantoprazole group requiring endoscopic hemostasis (risk difference [RD] −3.1%, 95% CI −11.6% to 4.6%). Rebleeding within 30 days also showed no difference between groups (3.3% vs. 4.8%, RD −1.5%, 95% CI −10.1% to 7.0%). Gastric pH monitoring was completed in 48% (29/61) of the oral group and 41% (26/63) of the IV group. The median percentage of gastric pH > 6 was 56.3% (IQR 28.0%–92.0%) in the oral group and 27.3% (IQR 4.4%–77.7%) in the IV group ( p = 0.064).
Conclusions
High‐dose oral omeprazole may represent a feasible alternative to continuous IV pantoprazole in terms of preventing rebleeding at 72 h and 30 days and maintaining gastric pH > 6 among patients with peptic ulcer bleeding who underwent successful therapeutic hemostatic endoscopy. Trial Registration: Registration number: NCT04394663
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand.
- Division of Gastroenterology, Department of Medicine, Surin Hospital, Surin, Thailand.
- Department of Medicine, Surin Hospital, Surin, Thailand.
- Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence in Neurogastroenterology and Motility, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Kanteera Sriyudthsak
Förderung
- The Gastroenterological Association of Thailand (GAT)
- Guardian Angel Thrift
Zitieren
APA
Sriyudthsak, K., Nalinthassanai, N., Sriapiraksa, B., Rattanachaisit, P., Patcharatrakul, T., & Pittayanon, R. (2026). High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70566
Vancouver
Sriyudthsak K, Nalinthassanai N, Sriapiraksa B, Rattanachaisit P, Patcharatrakul T, Pittayanon R. High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70566
BibTeX
@article{Sriyudthsak2026,
author = {Sriyudthsak, Kanteera and Nalinthassanai, Nutbordee and Sriapiraksa, Bunyos and Rattanachaisit, Pakkapon and Patcharatrakul, Tanisa and Pittayanon, Rapat},
title = {High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70566}
}
EUVIMED